Clinical trial
The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers
NCT01148004 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 13, 2010
- Completion date
- July 29, 2013
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fenofibrate, glucuronosyltransferase, hiv, hypertriglyceridemia, protease inhibitors